Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

29.38EUR
11:35am EDT
Change (% chg)

€-0.55 (-1.84%)
Prev Close
€29.93
Open
€29.70
Day's High
€29.80
Day's Low
€29.20
Volume
83,843
Avg. Vol
78,631
52-wk High
€34.60
52-wk Low
€22.60

GRLSbn.MC

Chart for GRLSbn.MC

About

Grifols SA is a Spain-based company engaged in the healthcare sector. The Company is involved in the research, development, manufacturing and marketing of medical solutions for hospitals, which include plasma-derived therapies, as well as diagnosis and pharmaceutical products. Its activities are structured in five segments:... (more)

Overall

Beta: 0.27
Market Cap(Mil.): €11,758.34
Shares Outstanding(Mil.): 343.78
Dividend: 0.25
Yield (%): 1.23

Financials

  GRLSbn.MC Industry Sector
P/E (TTM): 26.37 35.92 38.01
EPS (TTM): 1.40 -- --
ROI: 6.42 16.11 15.44
ROE: 17.86 16.90 16.48
Search Stocks

Spain's Grifols core profit rises 3.6 pct y/y to 280 mln euros

MADRID, May 7 - Spanish healthcare firm Grifols on Thursday posted a 3.6 percent rise in first-quarter earnings before interest, tax, debt and amortization (EBITDA) to 280 million euros ($318.00 million), helped by a strengthening dollar against the euro.

07 May 2015

BRIEF-Spain's Grifols buys 45 percent of Alkahest for $37.5 million

* Says buys 45 percent of U.S. biopharmaceutical company Alkahest for $37.5 million

04 Mar 2015

BRIEF-Spain's Grifols 2014 adjusted net profit rises 33 pct

* Says 2014 adjusted net profit 597.9 million euros ($679.57 million), up 32.8 percent from a year earlier and compared to 596 million euros in Reuters poll

26 Feb 2015

BRIEF-Spain's Grifols US purification plant cleared by regulator

* Says U.S. Food and Drug Administration has given the green light to a new Grifols Biologicals Inc. purification plant in Los Angeles, California

31 Dec 2014

Earnings vs. Estimates

Search Stocks